Employees: 03 (2023.0)Legal category: 5202Size: PMECreation date: 2005-12-08 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BONNY-SUR-LOIRE (45420), Loiret
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SNC PHARMACIE DE BONNY : revenue, balance sheet and financial ratios
SNC PHARMACIE DE BONNY is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BONNY-SUR-LOIRE (45420),
this company of category PME
shows in 2025 a net income positive of 153 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SNC PHARMACIE DE BONNY (SIREN 487811374)
Indicator
2025
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
152 538 €
124 023 €
123 545 €
163 677 €
166 891 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SNC PHARMACIE DE BONNY generates positive net income of 153 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 167 k€ -> 153 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
152 538 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 48%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
47.801%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.317%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SNC PHARMACIE DE BONNY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Debt ratio
124.428
90.818
84.936
67.183
47.801
Financial autonomy
36.823
44.271
45.896
48.925
56.317
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
47.82025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-6 pts over 3 years
In 2025, the debt ratio of SNC PHARMACIE DE BONNY (47.80) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
56.32%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+7 pts over 3 years
In 2025, the financial autonomy of SNC PHARMACIE DE BONNY (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 158.99. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
158.991
Liquidity indicators evolution SNC PHARMACIE DE BONNY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
2025
Liquidity ratio
154.981
168.775
170.212
151.547
158.991
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
158.992025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average
In 2025, the liquidity ratio of SNC PHARMACIE DE BONNY (158.99) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SNC PHARMACIE DE BONNY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SNC PHARMACIE DE BONNY is estimated at
2 423 084 €
(range 1 644 316€ - 3 802 152€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1644k€2423k€3802k€
2 423 084 €Range: 1 644 316€ - 3 802 152€
NAF 5 année 2025
Valuation method used
Net Income Multiple
152 538 €
×
15.9x
=2 423 084 €
Range: 1 644 316€ - 3 802 153€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SNC PHARMACIE DE BONNY with other companies in the same sector:
Frequently asked questions about SNC PHARMACIE DE BONNY
What is the revenue of SNC PHARMACIE DE BONNY ?
The revenue of SNC PHARMACIE DE BONNY is not publicly disclosed (confidential accounts filed with INPI).
Is SNC PHARMACIE DE BONNY profitable?
Yes, SNC PHARMACIE DE BONNY generated a net profit of 153 k€ in 2025.
Where is the headquarters of SNC PHARMACIE DE BONNY ?
The headquarters of SNC PHARMACIE DE BONNY is located in BONNY-SUR-LOIRE (45420), in the department Loiret.
Where to find the tax return of SNC PHARMACIE DE BONNY ?
The tax return of SNC PHARMACIE DE BONNY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SNC PHARMACIE DE BONNY operate?
SNC PHARMACIE DE BONNY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart